165 related articles for article (PubMed ID: 35584242)
41. State Medicaid coverage for tobacco-dependence treatments--United States, 2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(5):117-22. PubMed ID: 18256583
[TBL] [Abstract][Full Text] [Related]
42. Predictors of Pharmacotherapy for Tobacco Use Among Veterans Admitted for COPD: The Role of Disparities and Tobacco Control Processes.
Melzer AC; Feemster LC; Collins MP; Au DH
J Gen Intern Med; 2016 Jun; 31(6):623-9. PubMed ID: 26902236
[TBL] [Abstract][Full Text] [Related]
43. Direct observation of Medicaid beneficiary attempts to fill prescriptions for nicotine replacement medications.
Richter KP; Shergina E; Grodie A; Massey JK; Ellerbeck EF; Applegate A; Faseru B
J Am Pharm Assoc (2003); 2018; 58(4):432-437. PubMed ID: 29691198
[TBL] [Abstract][Full Text] [Related]
44. Associations of tobacco cigarette use and dependence with substance use disorder treatment completion by sex/gender and race/ethnicity.
Min JY; Levin J; Weinberger AH
J Subst Abuse Treat; 2022 Sep; 140():108834. PubMed ID: 35803029
[TBL] [Abstract][Full Text] [Related]
45. How Medicaid and Other Public Policies Affect Use of Tobacco Cessation Therapy, United States, 2010-2014.
Ku L; Brantley E; Bysshe T; Steinmetz E; Bruen BK
Prev Chronic Dis; 2016 Oct; 13():E150. PubMed ID: 27788063
[TBL] [Abstract][Full Text] [Related]
46. State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Accessing Treatments - United States, 2018-2022.
DiGiulio A; Tynan MA; Schecter A; Williams KS; VanFrank B
MMWR Morb Mortal Wkly Rep; 2024 Apr; 73(14):301-306. PubMed ID: 38602885
[TBL] [Abstract][Full Text] [Related]
47. Does Medicaid coverage of Medicare cost sharing affect physician care for dual-eligible Medicare beneficiaries?
Roberts ET; Desai SM
Health Serv Res; 2021 Jun; 56(3):528-539. PubMed ID: 33778957
[TBL] [Abstract][Full Text] [Related]
48. Facility-level, state, and financial factors associated with changes in the provision of smoking cessation services in US substance abuse treatment facilities: Results from the National Survey of Substance Abuse Treatment Services 2006 to 2012.
Cohn A; Elmasry H; Niaura R
J Subst Abuse Treat; 2017 Jun; 77():107-114. PubMed ID: 28476262
[TBL] [Abstract][Full Text] [Related]
49. Electronic Cigarette Use During a Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries with Mental Illness.
Bianco CL; Pratt SI; Ferron JC; Brunette MF
J Dual Diagn; 2019; 15(3):184-191. PubMed ID: 31169077
[No Abstract] [Full Text] [Related]
50. Physician and enrollee knowledge of Medicaid coverage for tobacco dependence treatments.
McMenamin SB; Halpin HA; Ibrahim JK; Orleans CT
Am J Prev Med; 2004 Feb; 26(2):99-104. PubMed ID: 14751319
[TBL] [Abstract][Full Text] [Related]
51. Enrollment in Supplemental Insurance Coverage Among Medicare Beneficiaries by Race/Ethnicity.
Park S; Meyers DJ; Rivera-Hernandez M
J Racial Ethn Health Disparities; 2022 Oct; 9(5):2001-2010. PubMed ID: 34580825
[TBL] [Abstract][Full Text] [Related]
52. Association of polysubstance use disorder with treatment quality among Medicaid beneficiaries with opioid use disorder.
Smart R; Kim JY; Kennedy S; Tang L; Allen L; Crane D; Mack A; Mohamoud S; Pauly N; Perez R; Donohue J
J Subst Abuse Treat; 2023 Jan; 144():108921. PubMed ID: 36327615
[TBL] [Abstract][Full Text] [Related]
53. Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries.
Burns ME; Busch AB; Madden JM; Le Cates RF; Zhang F; Adams AS; Ross-Degnan D; Soumerai SB; Huskamp HA
Psychiatr Serv; 2014 Mar; 65(3):323-9. PubMed ID: 24337444
[TBL] [Abstract][Full Text] [Related]
54. Factors Influencing Receipt of Interventional Pain Management Among Medicaid Beneficiaries with Cancer.
Halpern MT; Fiero MH
Pain Physician; 2019 May; 22(3):E147-E155. PubMed ID: 31151338
[TBL] [Abstract][Full Text] [Related]
55. Pilot study of enhanced tobacco-cessation services coverage for low-income smokers.
Doescher MP; Whinston MA; Goo A; Cummings D; Huntington J; Saver BG
Nicotine Tob Res; 2002; 4 Suppl 1():S19-24. PubMed ID: 11945215
[TBL] [Abstract][Full Text] [Related]
56. Medicaid coverage and utilization of covered tobacco-cessation treatments: the Arkansas experience.
Li C; Dresler CM
Am J Prev Med; 2012 Jun; 42(6):588-95. PubMed ID: 22608374
[TBL] [Abstract][Full Text] [Related]
57. Tobacco Cessation in Affordable Care Act Medicaid Expansion States Versus Non-expansion States.
Bailey SR; Marino M; Ezekiel-Herrera D; Schmidt T; Angier H; Hoopes MJ; DeVoe JE; Heintzman J; Huguet N
Nicotine Tob Res; 2020 May; 22(6):1016-1022. PubMed ID: 31123754
[TBL] [Abstract][Full Text] [Related]
58. Increasing consumer demand among Medicaid enrollees for tobacco dependence treatment: the Wisconsin "Medicaid covers it" campaign.
Keller PA; Christiansen B; Kim SY; Piper ME; Redmond L; Adsit R; Fiore MC
Am J Health Promot; 2011; 25(6):392-5. PubMed ID: 21721965
[TBL] [Abstract][Full Text] [Related]
59. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data.
Pauly NJ; Talbert JC; Brown J
J Manag Care Spec Pharm; 2016 Jun; 22(6):741-51. PubMed ID: 27231801
[TBL] [Abstract][Full Text] [Related]
60. Medicaid Coverage Expansions and Cigarette Smoking Cessation Among Low-income Adults.
Koma JW; Donohue JM; Barry CL; Huskamp HA; Jarlenski M
Med Care; 2017 Dec; 55(12):1023-1029. PubMed ID: 29068908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
